Functional Analysis of BARD1 Missense Variants in Homology‐Directed Repair of DNA Double Strand Breaks

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Mutation

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/humu.22902PMID 26350354PMCID PMC6005381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2017cited by this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cited by this paper
• Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel

  2015cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Gene-panel sequencing and the prediction of breast-cancer risk.

  2015cited by this paper
• Guidelines for investigating causality of sequence variants in human disease

  2014cited by this paper
• Analysis of BRCA1 Variants in Double‐Strand Break Repair by Homologous Recombination and Single‐Strand Annealing

  2013cited by this paper
• A high-throughput functional complementation assay for classification of BRCA1 missense variants.

  2013cited by this paper
• Hereditary ovarian cancer: beyond the usual suspects.

  2012cited by this paper
• Defective homologous recombination in human cancers.

  2012cited by this paper
• Predicting the Functional Effect of Amino Acid Substitutions and Indels

  2012cited by this paper
• Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families

  2012cited by this paper
• The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population

  2012cited by this paper
• Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

  2011cited by this paper
• Cancer predisposing BARD1 mutations in breast–ovarian cancer families

  2011cited by this paper
• Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010influential reference
• Impact of RING and BRCT Domain Mutations on BRCA1 Protein Stability, Localization and Recruitment to DNA Damage

  2010cited by this paper
• Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

  2010cited by this paper
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cited by this paper
• Cancer predisposing missense and protein truncating BARD1 mutations in non‐BRCA1 or BRCA2 breast cancer families

  2010cited by this paper
• HERC 2 Is an E 3 Ligase That Targets BRCA 1 for Degradation

  2010cited by this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010influential reference
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009influential reference
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009influential reference
• The 3′ processing factor CstF functions in the DNA repair response

  2008cited by this paper
• The BARD1 C-Terminal Domain Structure and Interactions with Polyadenylation Factor CstF-50

  2008cited by this paper
• The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression

  2008cited by this paper
• Genetic predisposition to breast cancer: past, present, and future.

  2008cited by this paper
• Standards and guidelines

  2007cited by this paper
• Cancer risks among BRCA1 and BRCA2 mutation carriers

  2007cited by this paper
• Structural Requirements for the BARD1 Tumor Suppressor in Chromosomal Stability and Homology-directed DNA Repair*

  2007influential reference
• Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

  2007cited by this paper
• Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

  2007cited by this paper
• The emerging landscape of breast cancer susceptibility

  2007cited by this paper
• Prevalence of Pathogenic BRCA 1 Mutation Carriers in 5 US Racial / Ethnic Groups

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.

  2006cited by this paper
• BRCA 1 DNA-Binding Activity Is Stimulated by BARD 1

  2006cited by this paper
• BRCA1 DNA-binding activity is stimulated by BARD1.

  2006cited by this paper
• BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

  2006cited by this paper
• Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression*

  2004cited by this paper
• The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair.

  2003cited by this paper
• Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein*

  2003cited by this paper
• Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

  2003cited by this paper
• BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• Accounting for human polymorphisms predicted to affect protein function.

  2002influential reference
• Identification of Residues Required for the Interaction of BARD1 with BRCA1*

  2002influential reference
• Germline mutations of the BRCA1‐associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

  2002cited by this paper
• Tumorigenesis in mice carrying a truncating Brca1 mutation.

  2001cited by this paper
• Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

  2001cited by this paper
• Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

  2001cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999cited by this paper
• Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

  1998cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper

• DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy

  2025cites this paper
• Saturation genome editing of BARD1 resolves VUS and provides insight into BRCA1-BARD1 tumor suppression

  2025cites this paper
• Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer.

  2025cites this paper
• Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

  2024cites this paper
• Health research in the era of artificial intelligence: Advances in gene-editing study

  2024cites this paper
• In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination.

  2023cites this paper
• Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants

  2022cites this paper
• SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation

  2021cites this paper
• The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Aktualisierte Kriterien des Deutschen Konsortiums Familiärer Brust- und Eierstockkrebs zur Klassifizierung von Keimbahn-Sequenzvarianten in Risikogenen für familiären Brust- und Eierstockkrebs

  2021cites this paper
• Functional interrogation of DNA damage response variants with base editing screens.

  2021cites this paper
• CT Irradiation-induced Changes of Gene Expression within Peripheral Blood Cells

  2020cites this paper
• Novel mutations in the RING-finger domain of BRCA1 gene in clinically diagnosed breast cancer patients

  2020cites this paper
• The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1

  2020cites this paper
• Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers

  2020cites this paper
• Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers

  2020cites this paper
• p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability

  2020cites this paper
• Functional analysis of clinical BARD1 germline variants

  2019cites this paper
• Characterizing BRCA1 Variants Using Multiplex Functional Assays

  2019cites this paper
• Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity

  2019cites this paper
• Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

  2019cites this paper
• A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.

  2018cites this paper
• A multiplexed homology-directed DNA repair assay reveals the impact of ~1,700 BRCA1 variants on protein function

  2018cites this paper
• BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes

  2018cites this paper
• BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number

  2018cites this paper
• Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling

  2017cites this paper
• Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53

  2017cites this paper
• Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms

  2017influential citation
• Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50

  2017cites this paper
• BRCA1/2 missense mutations and the value of in-silico analyses.

  2017cites this paper
• Hereditary breast and ovarian cancer: new genes in confined pathways

  2016cites this paper
• Variant requirements for DNA repair proteins in cancer cell lines that use alternative lengthening of telomere mechanisms of elongation

  2016cites this paper